CALIFORNIA HEALTHLINE - “The prospect for a broad measure at the federal level for doing something about pricing is probably zero,” said Dr. Walid Gellad associate professor of medicine and director of the Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh.
http://californiahealthline.org/news/momentum-to-regulate-drug-prices-uncertain-after-prop-61-defeat-republican-victories/
11/15/2016